Table 5.
Variables | 95%CI | P |
---|---|---|
Tumor Position (Right vs. Left&Rectum)# | 0.612 (0.407–0.919) | 0.018 |
Gender (Male vs. Female) | 1.428 (0.720–2.833) | 0.308 |
Age (<65 y vs. >=65 y) | 1.098 (0.549–2.196) | 0.791 |
Preoperative chemotherapy (No vs. Yes) | 3.295 (1.332–8.153) | 0.010 |
Preoperative radiation (No vs. Yes) | 0.048 (0–1858.733) | 0.573 |
Combined Resection (No vs. Yes) | 2.087 (0.863–5.046) | 0.102 |
Open or Laparoscopic (Open vs. Laparoscopic) | 0.611 (0.275–1.357) | 0.226 |
Gross Type (Protruding vs. (Ulcerative, Infiltratie)) | 1.919 (0.581–6.342) | 0.285 |
Circumference (<1/2 vs. >=1/2) | 1.037 (0.925–1.162) | 0.538 |
Differentiation (Well&Moderate vs. Poor) | 3.161 (1.560–6.407) | 0.001 |
T stage ((T1-T2) vs. (T3-T4)) | 5.586 (1.338–23.317) | 0.018 |
N (N0 vs. (N1-N2)) | 3.586 (1.673–7.686) | 0.001 |
M (M0 vs. M1) | 4.356 (2.211–8.579) | 0.000 |
TNM ((1–2) vs. (3–4)) | 2.673 (1.775–4.026) | 0.000 |
CEA (<5ng/mL vs. >=5ng/mL) | 2.007 (1.051–3.833) | 0.035 |
CA199 (<37 U/mL vs. >=37 U/mL) | 2.225 (1.106–4.473) | 0.025 |
KRAS (Wild vs. Mutant) | 0.945 (0.842–1.061) | 0.340 |
BRAF (Wild vs. Mutant) | 0.954 (0.856–1.064) | 0.397 |
Tumor Deposit (No vs. Yes) | 3.270 (1.659–6.445) | 0.001 |
Perineural Invasion (No vs. Yes) | 2.862 (1.414–5.789) | 0.003 |
Vascular Invasion (No vs. Yes) | 3.166 (1.556–6.444) | 0.001 |
MLH1 (Defect vs. Normal) | 0.966 (0.837–1.114) | 0.619 |
MSH2 (Defect vs. Normal) | 0.934 (0.785–1.111) | 0.438 |
MSH6 (Defect vs. Normal) | 0.905 (0.760–1.078) | 0.262 |
PMS2 (Defect vs. Normal) | 0.907 (0.755–1.090) | 0.298 |
β-Tubulin III ((−)~(+) vs. (++)~(+++)) | 1.016 (0.928–1.111) | 0.735 |
TOPIIα ((−)~(+) vs. (++)~(+++)) | 0.930 (0.748–1.158) | 0.518 |
P53 ((−)~(+) vs. (++)~(+++)) | 0.938 (0.774–1.137) | 0.514 |
Ki67 ((−)~(+) vs. (++)~(+++)) | 1.001 (0.811–1.237) | 0.991 |
#Right-sided colon cancer vs. Left -sided colon cancer & Rectal cancer.